Gram Negative Rod Peritonitis in Peritoneal Dialysis
1997; Wiley; Volume: 10; Issue: 1 Linguagem: Inglês
10.1111/j.1525-139x.1997.tb00458.x
ISSN1525-139X
Autores Tópico(s)Kidney Stones and Urolithiasis Treatments
ResumoSeminars in DialysisVolume 10, Issue 1 p. 38-45 Gram Negative Rod Peritonitis in Peritoneal Dialysis Douglas Shemin, Douglas Shemin Renal Division, Department of Medicine, Rhode Island Hospital, Brown University School of Medicine, Providence, Rhode IslandSearch for more papers by this author Douglas Shemin, Douglas Shemin Renal Division, Department of Medicine, Rhode Island Hospital, Brown University School of Medicine, Providence, Rhode IslandSearch for more papers by this author First published: 28 June 2008 https://doi.org/10.1111/j.1525-139X.1997.tb00458.xCitations: 4 Douglas Shemin MD Renal Division, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 DobbieJW: Surgical peritonitis: It relevance to thepathogenesis of peritonitis in CAPD.Perit Dial Int 8: 241–248, 1988 2 HolleyJL, BernardiniJ, PirainoB:Polymicrobial peritonitis in patients on continuous peritonealdialysis.Am J Kid Dis 19: 162–166, 1992 3 JawetzE, MelnickJL, AdelbergEA: Review of Medical Microbiology,(13th ed.) Los Altos, LangePublications,1978, pp. 209–2322 4 BernardiniJ, HolleyJL, JohnstonJR, PerlmutterJA, PirainoB:An analysis of ten year trends in infections in adults on continuousambulatory peritonitis (CAPD).Clin Neph 36: 29–34, 1991 5 KorbetSM, VoneshEF, FiranekCA:Peritonitis in an urban dialysis program: An analysis of infectingpathogens.Am J Kid Dis 26: 47–53, 1995 6 PollockCA, IbelsLS, CatersonRJ, MahonyJF, WaughDA, CocksedgeB: Continuous ambulatory peritoneal dialysis: Eight years of experience at asingle center. Medicine 293–306, 1989 7 RotellarC, BlackJ, WinchesterJF, RakowskiTA, MosherWF, MazzoniMJ, AmiranzaviM, GaragusiV, AlijaniMR, ArgyWP:Ten years' experience with continuous ambulatory peritoneal dialysis.Am J Kid Dis 17: 158–164, 1991 8 TranaeusA, HeimburgerO, LindholmB:Peritonitis in continuous ambulatory peritoneal dialysis (CAPD):Diagnostic findings, therapeutic outcome, and complications.Perit Dial Int 9: 179–190, 1989 9 Cendorogio NetoM, DalboniMA, VenturalRTP, RabelloT, BarbosaDA, DraibeS, AjzenH:High prevalence of s. aureus in CAPD patients in Brazil.Perit Dial Int 13:S 1–60, 1993 10 LyeWC, LeongSO, Van Der StraatenJC, LeeEJC:A prospective study of peritoneal dialysis-related infections in CAPDpatients with diabetes mellitus.Adv Perit Dialysis 9: 195–197, 1933 11 HolleyJ, BernardiniJ, PirainoB:Catheter infections in insulin-dependent diabetics on continuousambulatory peritoneal dialysis.Perit Dial Int 11: 347–350, 1991 12 TebbinJA, RigsbyMO, SelwynPA, BrennanN, KligerA, FinkelsteinFO:Outcome of HIV infected patients on continuous ambulatory peritonealdialysis.Kidney Int 44: 191–198, 1993 13 DresslerR, PetersAT, LynnRI:Pseudomonal and candidal peritonitis as a complication of continuousambulatory peritoneal dialysis patients in human immunodeficiencyvirus-infected patients.Am J Med 86: 787–790, 1989 14 MarcusRG, MessanaJ, SwartzR:Peritoneal dialysis in end-stage renal disease patients with preexistingchronic liver disease and ascites.Am J Med 93: 35–40, 1992 15 LevyM, BalfeJW:Optimal approach to the prevention and treatment of peritonitis inchildren undergoing continuous ambulatory and continuous cycling peritonealdialysis.Sem Dialysis 7: 442–449, 1994 16 HowardRL, MillspaughJ, TeitelbaumI:Adult and pediatric peritonitis rates in a home dialysis program:comparison of continuous ambulatory and continuous cycling peritonealdialysis.Am J Kid Dis 16: 469–472, 1990 17 HolleyJL, BernardiniJ, PerlmutterJA, PirainoB:A comparison of infection rates among older and younger patients oncontinuous peritoneal dialysis.Perit Dial Int 14: 66–69, 1994 18 PirainoB, BernardiniJ, CentaPK, JohnstonJR, SorkinMI:The effect of body weight on CAPD related infections and catheterloss.Perit Dial Int 11: 64–68, 1991 19 HolleyJL, BernardiniJ, PirainoB:A comparison of peritoneal dialysis-related infections in black and whitepatients.Perit Dial Int 13: 45–49, 1993 20 PirainoB, BernardiniJ, HolleyJL, PerlmutterJA:A comparison of peritoneal dialysis-related infections in short and longterm peritoneal dialysis patients.Perit Dial Int 13: 194–197, 1993 21 GahrmaniN, Gorban-BrennanN, KligerAS, FinkelsteinFO:Infection rates in end-stage renal disease patients treated with CCPD andCAPD using the ultrabag system.Adv Perit Dial 11: 164–167, 1995 22 De FijterCWH, OeLP, NautaJJP, Van Der MeulenJ, VerbrughHA, VerhoefJ, DonkerAJM:Clinical efficacy and morbidity associated with continuous cyclic comparedwithcontinuous ambulatory peritoneal dialysis.Ann Int Med 120: 264–271, 1994 23 LadouceurD, HopmanW, MortonAR: A comparison of infection rates betweenCAPD and CCPD.Perit Dial Int 14: S68, 1994 24 HolleyJL, BernardiniJ, PirainoB:Infecting organisms in continuous ambulatory peritoneal dialysis patientson the Y-set.Am J Kid Dis 23: 569–573, 1994 25 Canadian CAPD Clinical Trials Group: Peritonitis in continuous ambulatoryperitoneal dialysis (CAPD): A multi-centre randomized clinical trial comparingthe Y connectordisinfectant system to standard systems.Perit Dial Int 9: 159–163, 1989 26 TsakirisD, VakinisP, VisvardisG, TsatrafylliasP, AntoniadouR, KyrouA, PapadimitrouM:A five year epidemiology of peritonitis and sensitivity of microorganismsto antibiotics in one center.Perit Dial Int 12: S66, 1992 27 PirainoB:A review ofstaphylococcus aureus exit site and tunnel infections in peritonealdialysis patients.Am J Kid Dis 16: 89–95, 1990 28 AbrahamG, SavinE, AyiomamatisA, IzattS, VasSI, MathewsRE, OreopoulosDG:Natural history of exit-site infection (ESI) in patients on continuousambulatory peritoneal dialysis (CAPD).Perit Dial Int 8: 211–216, 1988 29 BernardiniJ, PirainoB, SorkinM:Analysis of continuous ambulatory peritoneal dialysis-related pseudomonasaeruginosa infections.Am J Med 83: 829–832, 1987 30 BunkeM, BrierME, GolperTA:Pseudomonas peritonitis in peritoneal dialysis patients: the Network#9 peritonitis study.Am J Kid Dis 25: 769–744, 1995 31 JuergensenPH, FinkelsteinFO, BrennanR, SantacroceS, AhernMJ:Pseudomonas peritonitis associated with continuous ambulatory peritonealdialysis: A six-year study.Am J Kid Dis 11: 413–417, 1988 32 KrothapalliR, DuffyWB, LackeC, PayneW, PatelH, PerezV, SenekjianH:Pseudomonas peritonitis and continuous ambulatory peritonealdialysis.Arch Int Med 142: 1862–1863, 1982 33 NguyenV, SwartzRD, ReynoldsJ, WilsonD, PortFK:Successful treatment of pseudomonas peritonitis during continuousambulatory peritoneal dialysis.Am J Nephrol 7: 38–43, 1987 34 KorzetsZ, ErdbergA, GolanE, BernheimJ: Pseudomonas peritonitis in CAPD.Perit Dial Int 12: S64, 1992 35 BerkelmanRL, GodleyJ, WeberJA, AndersonRL, LernerAM, PetersenNJ, AllenJR:Pseudomonas cepacia peritonitis assoicated with contamination ofautomatic peritoneal dialysis machines.Ann Int Med 96: 456–458, 1982 36 KolmosHJ, AndersenKE:Peritonitis with pseudomonas aeruginosa in hospital patients treated withperitoneal dialysis.Scand J Inf Dis 11: 207–210, 1979 37 ParrottPL, TerryPM, WhitworthEN, FrawleyLW, CobleRS, WachsmuthIK, McGowanJE:Pseudomonas aeruginosa peritonitis associated with contaminatedpoloxamer-iodine solution.Lancet ii: 683–685, 1982 38 RutherfordPC, NarkowiczJE, WoodCJ, PeelMM:Peritonitis caused bypseudomonas mesophilica in a patient undergoing continuousambulatory peritoneal dialysis.J Clin Micro 26: 2441–2443, 1988 39 TzamaloukasAH, MurataGH, FoxL: Peritoneal catheter loss and death in continuous ambulatory peritonealdialysis peritonitis: Correlation with clinical and biochemicalparameters. Perit Dial Int S338–S340, 1993 40 PirainoB, BernardiniJ, SorkinM:A five-year study of the microbiologic results of exit site infections andperitonitis in continuous ambulatory peritoneal dialysis.Am J Kid Dis 10: 281–286, 1987 41 DasguptaMK, WardK, NoblePA, LarabieM, CostertonJW:Development of bacterial biofilms on silastic catheter materials inperitoneal dialysis fluid.Am J Kid Dis 23: 709–716, 1994 42 BustosE, RotellarC, MazzoniMJ, RakowskiTA, ArgyWP, WinchesterJF:Clinical aspects of bowel perforation in patients undergoing continuousambulatory peritoneal dialysis.Sem Dialysis 7: 355–359, 1994 43 WakeenM, ZimmermanSW, BidwellD:Viscus perforation in peritoneal dialysis patients diagnosis andoutcome.Perit Dial Int 14: 371–377, 1994 44 MorduchowiczG, Van DykD, WittenbergC, WinklerJ, BonerG:Bacteremia complicating peritonitis in peritoneal dialysis patients.Am J Nephrol 13: 278–280, 1993 45 PetersenJH, WeesnerRE, GianellaRA:Escherichia coli peritonitis after left-sided colonoscopy in a patient oncontinuous ambulatory peritoneal dialysis.Am J Gastro 82: 171–172, 1987 46 VergerC, DanneO, VuilleminF:Colonoscopy and continuous ambulatory peritoneal dialysis.Gastro Endosc 33: 334–335, 1987 47 BlakeP, AbrahamG, BargmanJ, VasS, MathewsR, HaberstrohB, OreopoulosDG:Splenic abscess and peritonitis in a continuous ambulatory peritonealdialysis (CAPD) patient.Perit Dial Int 9: 73–74, 1989 48 RodbyRA, MurataGH, FoxL, TzamaloukisAH:Baby poop peritonitis.Perit Dial Int 10: 99–103, 1990 49 CaruanaRJ, WolfmanNT, KarstaedtN, WilsonDJ:Pancreatitis: An important cause of abdominal symptoms in patients onperitoneal dialysis.Am J Kid Dis 7: 135–140, 1986. 50 GalvaoC, SwartzR, RocherL, ReynoldsJ, StarmannB, WilsonD:Acinetobacter peritonitis during chronic peritoneal dialysis.Am J Kid Dis 14: 101–104, 1989 51 LyeWC, LeeEJC, LeongSO, KumarasinghG:Clinical characteristics and outcome ofacinetobacter infections in CAPD patients.Perit Dial Int 14: 174–177, 1994 52 ValdezJM, AsperillaMO, SmegoRA:Acinetobacter peritonitis in continuous ambulatory peritonealdialysis.Southern Med J 84: 607–610, 1991 53 RuizA, RamosB, BurgosD, FrutosMA, Lopez de NovalesE:Acinetobacter calcoaceticus peritonitis in continuous ambulatoryperitoneal dialysis patients.PeritDial Int 8: 285–286, 1988 54 AbruytnE, GoodhartGL, RoosK:Acinetobacter calcoaceticus outbreak associated with peritonealdialysis.Am J Epidemiol 107: 328–335, 1978 55 Van den EndenE, CabuyA, DaelemansR, VerhaegenJ, LinsR:Campylobacter jejuni peritonitis during chronic ambulatory peritonealdialysis (CAPD).Perit Dial Int 10: 177–178, 1990 56 WoodCJ, FlemingV, TurnridgeJ, ThomsonN, AtkinsRC:Campylobacter peritonitis in continuous ambulatory peritonealdialysis: Report of eight cases and a review ofthe literature.Am J Kid Dis 19: 257–263, 1992 57 OrrKE, WilkinsonR, GouldFK:Salmonella enteritis causing CAPD peritonitis.Perit Dial Int 13: 164, 1993 58 ElseyRM, CarsonRW, DuBoseTD:Pasteurella multocida peritonitis in an HIV-positive patient on continuouscycling peritoneal dialysis.Am J Nephrol 11: 61–63, 1991 59 PaulRV, RostandSG:Cat-bite peritonitis:Pasteurella multocida peritonitis following feline contamination ofperitoneal dialysis tubing.Am J Kid Dis 10: 318–319, 1987 60 ByrdLH, AnamaL, GutkinM, ChmelH:Bordetella bronchiseptica peritonitis associated with continuousambulatory peritoneal dialysis.J Clin Micro 14: 232–233, 1981 61 TaylorR, McDonaldM, RussG, CarsonM, LukaczynskiE:Vibrio alginolyticus peritonitis associated with ambulatoryperitoneal dialysis.Br Med J 283: 275, 1981 62 FessiaS, RyanS:Haemophilus parainfluenza biotype II associated with peritonitis duringcontinuous ambulatory peritoneal dialysis.Perit Dial Int 8: 56–57, 1988 63 Al-WaliW, BaillodR, Hamilton-MillerJM, BrumfittW:Detective work in continuous ambulatory peritoneal dialysis.J Infection 20: 151–154, 1990 64 RodbyRA, GlickEJ:Agrobacterium radiobacter peritonitis in two patients maintained onchronic peritoneal dialysis.Am J Kid Dis 18: 402–405, 1991 65 LudlamHA, PriceTN, BerryAJ, PhillipsI:Laboratory diagnosis of peritonitis in patients on continuous ambulatoryperitoneal dialysis.J Clin Micro 26: 1757–1762, 1988 66 ShethNK, BartellCA, RothDA:In vitro study of bacterial growth in continuous ambulatory peritonealdialysis fluids.J Clin Micro 23: 1096–1098, 1986 67 BailieGR, EiseleG, VeneziaRA, LitynskiJ, HughesH:Recovery of s. epidermidis and e. coli from effluent peritonealdialysate.Perit Dial Int 11: 69–71, 1991 68 VasSI:The diagnosis of peritonitis in patients on continuous ambulatoryperitoneal dialysis.Sem Dialysis 8: 232–237, 1995 69 BurkartJ, HaiglerS, CaruanaR, HylanderB:Usefulness of peritoneal fluid amylase levels in the differentialdiagnosis of peritonitis in peritoneal dialysis patients.J Am Soc Nephrol 1: 1186–1190, 1991 70 JanknegtR:CAPD peritonitis and fluoroquinolones: A review.Perit Dial Int 11: 53–58, 1991 71 PlantWD, MartinU, BarronW, ScousePK, WinneyRJ, PrescottLF: Absorption andclearance of ceftazidime during CAPD.Perit Dial Int 15: 378–382, 1995 72 JohnsonCA, ZimmermanSW, RoggeM:The pharmacokinetics of antibiotics used to treat peritonealdialysis-associated peritonitis.Am J Kid Dis 4: 3–17, 1984 73 KeaneWF, EverettED, GolperTA, GokalR, HalsenstonC, KawaguchiY, RiellaM, VasS, VerbrughHA:Peritoneal dialysis-related peritonitis treatmentrecommendations 1993 update.Perit Dial Int 13: 14–28, 1993 74 TaberTE, HegemanTF, YorkSM, KinneyRA, WebbDH:Treatment of pseudomonas infections in peritoneal dialysis patients.Perit Dial Int 11: 213–216, 1991 75 PasadakisP, ThodisE, EftiminiadouA, PanagoutsosS, PapazoglouD, KaliengidouM, KartaliS, VargemezisV:Treatment and prevention of relapses of CAPDpseudomonas peritonitis.Adv Perit Dial 9: 206–210, 1993 76 KazmiHR, RaffoneD, KligerAS, FinkelsteinFO:Pseudomonas exit site infections in continuous ambulatory peritonealdialysis patients.J Am Soc Nephrol 10: 1498–1501, 1992 77 PolkRE:Drug-drug interactions with ciprofloxacin and other fluoroquinolones.Am J Med 87(5A): 76S–80S, 1989 78 BallP:Emergent resistance to ciprofloxacin amongstPseudomonas aeruginosa and Staphylococcus aureus: Clinicalsignificance and therapeutic approaches.J Antimicrob Chemother 26supp F: 165–179, 1990 79 LyeWC, LeongSO:Neurotoxicity associated with intraperitoneal ceftazidime therapy in aCAPD patient.Perit Dial Int 14: 408–409, 1994 80 JacksonGG, ArcieriG:Ototoxicity of gentamicin in man: A survey and controlled analysis ofclinical experience in the United States.J Infect Dis 124: S130–S137, 1971 81 AubiaJ, HojmanL, ChineM, LloverasJ, MasramonJ, LlorachI, CuevasX, PuigJM:Hypertension and nephrotoxicity in kidney function in diabeticnephropathy.Clin Neph 27: 15–20, 1987 82 LyeWC, WongPL, Van Der StraatenJC, LeongSO, LeeEJ:A prospective randomized controlled comparison of single versus multidosegentamycin in the treatment of CAPD peritonitis.Perit Dial Int 15: S30, 1995 83 DratwaM, GlupczynskiY, LamiereN, MatthysD, VerschraegenG, Van EeckhouteM, BoelaertJ, SchurgersM, Van LanduytH, VerbeelenD, LauwersS.Aztreonam in CAPD peritonitis.Lancet ii: 213–214, 1987 84 PasadakisP, VargemezisV, ThodisE, GogouG, PeihaberisP, JaferH:Ceftazidime as monotherapy in CAPD peritonitis.Perit Dial Int 9: S1, abstract 136, 1989 85 BeamanM, SolaroL, McGonigleRJ, MichaelJ, AduD:Vancomycin and ceftazidime in the treatment of CAPD peritonitis.Nephron 51: 51–55, 1989 86 Perez FontanM, RosalesM, Rodriguez-CarmonaA, Garcia FalconT, AdevaM, Fernandez RiveraC, MoncalianJ:Treatment of peritonitis in CAPD with ciprofloxacin:Long-term experience.Adv Perit Dial 9: 211–214, 1993 87 LudlamHA, BartonI, WhiteL, McMullinC, KingA, PhillipsI:Intraperitoneal ciprofloxacin for the treatment of peritonitis in patientsreceiving continuous ambulatoryperitoneal dialysis (CAPD).J Antimicrob Chemo 25: 843–851, 1990 88 FlemingLW, PhillipsG, MorelandTA, StewartWK, ScottAC:Oral ciprofloxacin for treatment of peritonitis in patients on continuousambulatory peritoneal dialysis.Rev Inf Dis 11: S1294–S1296, 1989 89 TapsonJS, OrrKE, GeorgeJC, StansfieldE, BintAJ, WardMK:A comparison between oral ciprofloxacin and intraperitoneal vancomycin andnetlimicin in CAPD peritonitis.J Antimicrob Chemother 26(supp F): 63–71, 1990 90 SheminD, MaazD:Gram negative peritonitis: improved outcome with intraperitonealceftazidime.Perit Dial Int 16: s2–s4, 1996 91 NankivellBJ, LakeN, GilliesA: Intracatheter streptokinase for recurrent peritonitisin CAPD.Clin Neph 35: 20–23, 1991 92 BeneventD, PeyronnetP, BrignonP, Leroux-RobertC:Urokinase infusion for obstructed catheters and peritonitis.Perit Dial Bull 5: 77, 1985 93 WilliamsAJ, BoletisI, JohnsonBF, RafteryAT, CohenGL, MoorheadPJ, El NahasAM, BrownCB:Tenckhoff catheter replacement or intraperitoneal urokinase: a randomizedtrialin the management of recurrent continuous ambulatory peritoneal dialysis (CAPD)patients.Perit Dial Bull 9: 65–67, 1989 94 PirainoB, BernardiniJ, PeitzmanA, SorkinM:Failure of peritoneal catheter cuff shaving to eradicate infection.Perit Dial Bull 7: 179–182, 1987 95 SwartzR, MessanaJ, ReynoldsJ, RanjitU:Simultaneous catheter replacement and removal in refractory peritonealdialysis infections.Kidney Int 40: 1160–1165, 1991 96 LuzarMA, SlingeneyerA, CantaluppiA, PelusoP:In vitro study of the flush effect in two reusable continuous ambulatoryperitoneal dialysis (CAPD) disconnect systems.Perit Dial Int 9: 169–173, 1989 97 AxelrodJ, MeyersBR, HirschmanSZ, SteinR:Prophylaxis with cephalothin in peritoneal dialysis.Arch Int Med 132: 368–371, 1973 98 LowDE, VasSI, OreopoulosDE, ManuelMA, SaiphooMM, FinerC, DombrosN:Prophylactic cephelexin ineffective in chronic ambulatory peritonealdialysis.Lancet ii: 753–754, 1980 99 ChurchillDN, TaylorDW, VasSI, SingerJ, BeecroftML, WuG, ManuelA, PatonT, WalkerS, SmithEKM, OreopoulosDG: Peritonitis in continuous ambulatory peritoneal dialysis(CAPD) patients: A randomized clinical trial of cotrimoxazole prophylaxis. Perit Dial Int 125–128, 1988 Citing Literature Volume10, Issue1January 1997Pages 38-45 ReferencesRelatedInformation
Referência(s)